Altogether, analysis of all three intestinal inflammatory models (DSS, TNFΔARE and IL10 null mice) is consistent with the pathologic role of macrophages in gut inflammation, which may be targeted by aCSF1 and aIL34 therapeutics. This evidence concerns the gene IL10 and inflammation.